Macquarie Group LTD Wave Life Sciences Ltd. Transaction History
Macquarie Group LTD
- $90.3 Billion
- Q3 2024
A detailed history of Macquarie Group LTD transactions in Wave Life Sciences Ltd. stock. As of the latest transaction made, Macquarie Group LTD holds 81,955 shares of WVE stock, worth $1.17 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
81,955
Previous 81,955
-0.0%
Holding current value
$1.17 Million
Previous $408,000
64.71%
% of portfolio
0.0%
Previous 0.0%
Shares
1 transactions
Others Institutions Holding WVE
# of Institutions
164Shares Held
117MCall Options Held
148KPut Options Held
109K-
Ra Capital Management, L.P. Boston, MA18.2MShares$260 Million2.08% of portfolio
-
Lee Ainslie Maverick Capital LTD | Dallas, Tx10MShares$143 Million1.71% of portfolio
-
Adage Capital Partners Gp, L.L.C. Boston, MA9.7MShares$138 Million0.15% of portfolio
-
Black Rock Inc. New York, NY6.74MShares$96.1 Million0.0% of portfolio
-
M28 Capital Management LP Stamford, CT6.16MShares$87.9 Million48.05% of portfolio
About Wave Life Sciences Ltd.
- Ticker WVE
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 86,820,096
- Market Cap $1.24B
- Description
- Wave Life Sciences Ltd., a clinical stage genetic medicine company, designs, optimizes, and produces novel stereopure oligonucleotides through PRISM, a discovery and drug developing platform. It is developing oligonucleotides target ribonucleic acid to reduce the expression of disease-promoting proteins or restore the production of functional pr...